日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials

特拉洛奇尤单抗治疗中重度特应性皮炎成人患者的疗效和安全性:III期试验的事后分析

Mayo, Tiffany; Silverberg, Jonathan I; Armstrong, April; Guttman-Yassky, Emma; Blauvelt, Andrew; Esdaile, Ben; Kabashima, Kenji; Gooderham, Melinda; Kircik, Leon; Schneider, Shannon; Bennike, Niels; von Eyben, Rie; Martel, Britta C; Røpke, Mads A; Katoh, Norito; Alexis, Andrew F

Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis

tralokinumab治疗中重度特应性皮炎成人患者长达4年的疗效

Gooderham, Melinda; Ameen, Mahreen; Hong, H Chih-Ho; Katoh, Norito; Langley, Richard G; Peris, Ketty; Reich, Kristian; Silvestre, Juan F; Simpson, Eric; Werfel, Thomas; Gjerum, Le; Tindberg, Ann-Marie; Øland, Christian Bjerregård; Blauvelt, Andrew

Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years

在为期 6 年的随机临床试验中,upadacitinib 治疗特应性皮炎的安全性

Bunick, Christopher G; Irvine, Alan D; Silverberg, Jonathan I; Guttman-Yassky, Emma; Shahriari, Mona; Gao, Xinghua; Weidinger, Stephan; Katoh, Norito; Vigna, Namita; Dilley, Deanne M; D'Andrea, Elvira; Teixeira, Henrique D; Platt, Andrew M; Levy, Gweneth F

The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA(2)LEN ADCARE statement paper

特应性皮炎及相关皮肤炎症性疾病局部应用皮质类固醇治疗的有效和无效定义:GA(2)LEN ADCARE声明文件

Zuberbier, Torsten; Abuzakouk, Mohamed; Angelova Fischer, Irena; Arruda, Luisa Karla; Augustin, Matthias; Beck, Lisa; Bernstein, Jonathan; Bindslev-Jensen, Carsten; Bertolín-Colilla, Marta; Bangert, Christine; Calderón-Llosa, Oscar; Canonica, Giorgio Walter; Roldan-Castor, Mary Anne; Casis-Hao, Roxanne J; Cherrez-Ojeda, Ivan; Choo, Karen Jui Lin; Chularojanamontri, Leena; Cork, Michael J; Craig, Timothy J; Criado, Paulo Ricardo; Custovic, Adnan; Çetinarslan, Tubanur; Çalıcıoğlu, Furkan; de Bruin-Weller, Marjolein; Douladiris, Nikolaos; Ensina, Luis Felipe; Erdem Öztürk, Yasemin; Ertaş, Ragip; Ferrucci, Silvia Mariel; Rosário Filho, Nelson; Flohr, Carsten; Fluhr, Joachim; Fomina, Daria; Gregoriou, Stamatios; Gotua, Maia; Giménez-Arnau, Ana Maria; Hoetzenecker, Wolfram; Jack, Carolyn; Criado, Roberta Fachini Jardin; Katoh, Norito; Katoulis, Alexandros; Kökçü Karadağ, Şefika İlknur; Larenas-Linnemann, Desiree; Lee, Haur Yueh; Lima, Herminio; Mansour, Eli; Mortz, Charlotte G; Morelo Rocha Felix, Mara; Morris, Victor; Moschione Castro, Ana; Mota Veloso Bruscky, Dayanne; Mukhina, Olga; Nguyen, Dinh Van; Nosbaum, Audrey; Ozceker, Deniz; Özkaya, Esen; Oztas Kara, Rabia; Parisi, Claudio A S; Peter, Jonny; Puig, Luis; Ramon, German Dario; Rincón-Pérez, Catalina; Sahiner, Umit Murat; Schmid-Grendelmeier, Peter; Serra-Baldrich, Esther; Sevimli Dikicier, Bahar; Smith, Catherine H; Staubach, Petra; Stevanovic, Katarina; Su Kucuk, Ozlem; Teovska Mitrevska, Natasa; Thaci, Diamant; Torres, Maria Jose; Torres, Tiago; Trócoli Zanetti, Maria Eduarda; Tuchinda, Papapit; Vadasz, Zahava; Vakirlis, Efstratios; Vieira Duarte, Gleison; Virtanen, Hannele; Werfel, Thomas; Wollenberg, Andreas; Worm, Margitta; Yew, Yik Weng; Pereira, Manuel P

A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study

对 Amlitelimab STREAM-AD 2b 期研究中头颈部及其他身体部位特应性皮炎的事后分析

Reich, Adam; Blauvelt, Andrew; Weidinger, Stephan; Shi, Vivian Y; Katoh, Norito; Lynde, Charles; Gao, Xinghua; Armstrong, Nicole M; Bernigaud, Charlotte; Rahawi, Kassim

Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND

特拉洛奇尤单抗治疗中重度特应性皮炎患者长达6年的长期安全性和有效性:开放标签扩展试验ECZTEND的最终结果

Blauvelt, Andrew; Hong, H Chih-Ho; Katoh, Norito; Langley, Richard G; Laquer, Vivian; Lesiak, Aleksandra; Peris, Ketty; Seneschal, Julien; Silvestre, Juan-Francisco; Warren, Richard B; Wollenberg, Andreas; Zirwas, Matthew; Bennike, Niels Højsager; Safavimanesh, Farzaneh; Tindberg, Ann-Marie; Reich, Kristian

The Pathogenesis of Atopic Dermatitis-Trends for the Future

特应性皮炎的发病机制——未来发展趋势

Katoh, Norito

AI-Based Objective Severity Assessment of Atopic Dermatitis Using Patient Photos in a Real-World Setting: A Digital Biomarker Approach

基于人工智能的特应性皮炎客观严重程度评估:利用患者照片在真实世界环境中的应用——一种数字生物标志物方法

Okata-Karigane, Utako; Hirota, Masakazu; Takahashi, Chiaki; Miyagawa, Akihiro; Ako, Ryotaro; Nakajima, Saeko; Futamura, Masaki; Yonekura, Satoru; Ogawa, Yasushi; Inomata, Takenori; Ishikawa, Tetsuo; Ito, Yoshihiro; Masaki, Katsunori; Sato, Sakura; Katoh, Norito; Morita, Hideaki; Adachi, Takeya

Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis

Upadacitinib 与安慰剂(Measure Up 1 和 Measure Up 2)以及与 Dupilumab(Heads Up)相比,能快速改善瘙痒和清除皮肤:三项针对中重度特应性皮炎患者的 3 期临床试验结果

Simpson, Eric L; Silverberg, Jonathan I; Prajapati, Vimal H; Eyerich, Kilian; Katoh, Norito; Boguniewicz, Mark; Guttman-Yassky, Emma; Song, E James; Lee, Wan-Ju; Teixeira, Henrique D; Wu, Tianshuang; Sancho Sanchez, Cristina; Vigna, Namita; Calimlim, Brian M; de Bruin-Weller, Marjolein

Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2)

使用 Upadacitinib 治疗中重度特应性皮炎,实现最佳治疗目标和最小疾病活动度:3 期研究(Measure Up 1 和 2)的综合分析

Silverberg, Jonathan I; Gooderham, Melinda; Katoh, Norito; Aoki, Valeria; Pink, Andrew E; Binamer, Yousef; Glick, Brad; Staubach, Petra; Calimlim, Brian; Li, Chao; Grada, Ayman; Moreira, Alvaro; Lee, Wan-Ju; Wollenberg, Andreas